Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Enrico Bernardi a Istituto di Semeiotica Medica, University of
Padua, 35128 Padua, Italy, b Azienda Ospedaliera di Padova
Servizio di Angiologia, University of Padua, c Istituto di Medicina
Interna e Vascolare, Azienda Ospedaliera di Perugia, Policlinico
Monteluce, 06122 Perugia, Italy, d Divisione di Angiologia, Azienda
Ospedaliera S Orsola Malpighi, 40138 Bologna, Italy, e I Divisione Medica,
Ospedale Civile di Venezia, Venice 30100, Italy, f Medicina Interna e
Oncologia Medica, Policlinico San Matteo, Pavia Policlinico, Piazzale
Golgi 2, 27100 Pavia, Italy, g I Medicina, Ospedale di Bolzano, 39100 Bolzano,
Italy, h Ospedale Maggiore e Università di Milano, 20122 Milan, Italy, i Centre for
Vascular Medicine, Academic Medical Centre, H-2, 1105 AZ Amsterdam,
Netherlands
Correspondence to: Dr Lensing a.w.lensing{at}amc.uva.nl
Objective To investigate the efficacy of using a
rapid plasma D-dimer test as an adjunct to compression
ultrasound for diagnosing clinically suspected deep vein thrombosis.
Design D-dimer concentrations were
determined in all patients with a normal ultrasonogram at presentation.
Repeat ultrasonography was performed 1 week later only in patients with
abnormal D-dimer test results.
Main outcome measure Patients with normal
ultrasonograms were not treated with anticoagulants and were followed
for 3 months for thromboembolic complications.
Setting University research and affiliated centres.
Subjects 946 patients with clinically suspected deep
vein thrombosis.
Results Ultrasonograms were abnormal at presentation
in 260 (27.5%) patients. Of the remaining 686 patients tested for
D-dimer, 88 (12.8%) had abnormal concentrations. During
follow up venous thromboembolic complications occurred in one of the 598 patients who were not treated with anticoagulants and who had an
initial normal ultrasonogram and D-dimer concentration, whereas thromboembolic complications occurred in two of the 83 untreated patients who had abnormal D-dimer concentrations
but a normal repeat ultrasonogram. The cumulative incidence of venous thromboembolic complications during follow up was 0.4% (95%
confidence interval 0% to 0.9%). The rapid plasma D-dimer
test used as an adjunct to compression ultrasonography resulted in a
reduction in the mean number of repeat ultrasound examinations and
additional hospital visits from 0.7 to 0.1 per patient.
Conclusions Testing for D-dimer as an
adjunct to a normal baseline ultrasound examination decreased the
number of subsequent ultrasound examinations considerably without any
increased risk of venous thromboembolic complications in patients not
receiving anticoagulants. The use of ultrasound and testing for
D-dimer enabled treatment decisions to be made at the time
of presentation in most patients.
Key messages
Read all Rapid Responses